Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.99
Delayed Data
As of Feb 12
 +0.86 / +7.73%
Today’s Change
6.36
Today|||52-Week Range
21.16
+13.76%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close11.13
Today’s open11.28
Day’s range10.92 - 12.11
Volume857,181
Average volume (3 months)869,348
Market cap$1.4B
Dividend yield8.35%
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+448.75%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+176.68%
P/E ratioNM
Price/Sales22.54
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.68+1.93%
TSROTESARO Inc+1.13+3.23%
ACORAcorda Therapeutics ...+0.15+0.45%
CXRXConcordia Healthcare...+2.14+8.85%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$53.9M
Annual profit (last year)-$18.8M
Net profit margin-34.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers